Il tuo browser non supporta JavaScript!
Il bonus 18app scade a fine dicembre. Per non perdere il credito residuo convertilo in un buono regalo Scopri come

Libri di Jeffrey L. Cummings

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 3, 2008

Jeffrey L. Cummings

editore: Cambridge University Press

pagine: 312

Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.
128,00 108,80

Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 2, 2007

Jeffrey L. Cummings

editore: Cambridge University Press

pagine: 284

Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.
123,00 104,55

Dementia

A Global Approach

Ennapadam S. Krishnamoorthy, Jeffrey L. Cummings
e altri

editore: Cambridge University Press

pagine: 212

Growth in the incidence of dementia presents major challenges to global healthcare systems. As the burden of dementia in non-Western cultures grows, developing nations are expected to overtake developed nations in terms of dementia prevalence. Insights from developing nations and transcultural considerations are, nevertheless, neglected in the published literature. Dementia: A Global Approach fills this gap by integrating contemporary cross-cultural knowledge about dementia. Each section reviews the literature from the published, predominantly Western, perspective, contrasting it with empirical knowledge from non-Western cultures. Covering major clinical, epidemiological and scientific areas of interest, detailed consideration is also given to care-giving models across the world and management of patients who have migrated between regions. Enriched with personal insights from clinical experts across the globe, this is a key text for neurologists, geriatricians, psychiatrists, psychologists, epidemiologists and all those responsible for managing provisions of dementia services.
82,00 69,70

Dementia

C. W. Ritchie, Colin L. Masters
e altri

editore: Clinical Publishing,an imprint of Atlas Medical Publishing Ltd

pagine: 376

Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work, leading experts review the therapeutic agents currently available and assess their effectiveness. Also included is an update on recent and on-going clinical trials, the prospects for new therapeutic targets and the development of new biomarkers that will aid recognition of disease and thus earlier intervention.
88,00 74,80

The American Psychiatric Press Textbook of Geriatric Neuropsychiatry

C. Edward Coffey, Jeffrey L. Cummings

editore: American Psychiatric Press Inc.

pagine: 1088

For most of human history, life expectancy was remarkably stable at about 30A40 years. Within the past 150 years, however, medical advances have virtually doubled that number. The worldAs elderly population is growing at 2.4% per year, faster than the rest of the population, with disproportionate increases expected to continue as newer and better treatments are found that minimize the disabilities associated with advanced age. Key to improving the health and quality of life of the elderly is understanding and treating the brain diseases and behavioral disorders that become highly prevalent with age. Geriatric neuropsychiatry is an integrative specialty that draws from many diverse fields, including psychiatry, neurology, neuroscience, and geriatrics. It provides expertise on how to distinguish normal age-related changes from those of disease and disordered brain function. Edited by two eminent practitioners and educators, this wide-ranging textbookAs 41 chapters are divided into five major sections: -Introduction to Geriatric NeuropsychiatryAIntroduces the field, including the epidemiology of aging and its array of interacting and accumulating disadvantages, the neurobiology of aging, and the neurobiological basis of behavior -Neuropsychiatric Assessment of the ElderlyADescribes how to ensure early, accurate diagnoses, using both the fundamental cognitive skills evaluation and the more in-depth neuropsychological evaluation; age-associated memory impairment (AAMI) and its biological bases; anatomic imaging of age-related changes in brain morphology; and the latest imaging techniques that allow visualization of brain function in vivo -Neuropsychiatric Aspects of Psychiatric Disorders in the ElderlyACovers everything from affective and anxiety disorders, substance abuse, and psychoses that start late in life to sleep disorders, delirium, pain, contemporary personality psychology, mental retardation, and aggression -Neuropsychiatric Aspects of Neurological Disease in the ElderlyAFocuses on diseases such as nondegenerative dementing disorders, AlzheimerAs and ParkinsonAs diseases, hyperkinetic movement disorders, stroke, epilepsy, and traumatic brain injury, concluding with medical illnesses and therapies -Principles of Neuropsychiatric Treatment of the ElderlyADiscusses the effect of age in geriatric neuropsychopharmacology, psychopharmacology, ECT, psychosocial therapies, neuropsychiatry in nursing homes, genetic interventions, rehabilitation, ethical issues, and competency and related forensic issues Exhaustively researched and annotated, the American Psychiatric Press Textbook of Geriatric Neuropsychiatry, Second Edition provides a definitive core reference for psychiatry and neurology residents, particularly those pursuing a specialty in geriatrics, and for graduate students in psychology, neuropsychology, and related fields.
252,24 214,40

Manuale di neuropsichiatria geriatrica

C. Edward Coffey, Jeffrey L. Cummings

editore: CIC Edizioni Internazionali

pagine: 1070

92,96

Inserire il codice per il download.

Inserire il codice attivare il servizio.